Literature DB >> 15534598

Molecular genetic basis of primary inherited optic neuropathies.

M Votruba1.   

Abstract

AIM: To review the molecular genetic basis of primary inherited optic neuropathies.
METHODS: Medline and Embase search.
RESULTS: Inherited optic neuropathies are a genetically diverse group of disorders that present with reduced visual acuity and the clinical appearance of optic atrophy. The inherited optic neuropathies may be sporadic or familial, in which case the mode of inheritance may be Mendelian (autosomal dominant, autosomal recessive, X-linked recessive) or non-Mendelian (mitochondrial). Two genes for dominantly inherited optic atrophy have been mapped (OPA1 and OPA4), of which the gene has been identified in one (OPA1). A gene for recessive optic atrophy (OPA3) has also been identified. X-linked optic atrophy (OPA2) has been mapped but to date no gene has been identified. Mutations in mitochondrial DNA have been identified in Leber's hereditary optic neuropathy.
CONCLUSIONS: Mutations in genes from both the nuclear and mitochondrial genomes appear to be responsible. Mitochondrial dysfunction, in the broadest sense, is emerging as central to the pathogenesis of this group of conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15534598     DOI: 10.1038/sj.eye.6701570

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  17 in total

1.  Molecular epidemiology of mtDNA mutations in 903 Chinese families suspected with Leber hereditary optic neuropathy.

Authors:  Xiaoyun Jia; Shiqiang Li; Xueshan Xiao; Xiangming Guo; Qingjiong Zhang
Journal:  J Hum Genet       Date:  2006-09-14       Impact factor: 3.172

Review 2.  A hypothesis to suggest that light is a risk factor in glaucoma and the mitochondrial optic neuropathies.

Authors:  N N Osborne; G Lascaratos; A J Bron; G Chidlow; J P M Wood
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

3.  [Differential diagnosis of juvenile normal pressure glaucoma].

Authors:  K Geidel; P Wiedemann; J D Unterlauft
Journal:  Ophthalmologe       Date:  2017-09       Impact factor: 1.059

Review 4.  Mitochondrial Membrane Dynamics and Inherited Optic Neuropathies.

Authors:  Eleni Bagli; Anastasia K Zikou; Niki Agnantis; Georgios Kitsos
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

Review 5.  Optic atrophies in metabolic disorders.

Authors:  Marjan Huizing; Brian P Brooks; Yair Anikster
Journal:  Mol Genet Metab       Date:  2005-09-27       Impact factor: 4.797

6.  Clinical approach to optic neuropathies.

Authors:  Raed Behbehani
Journal:  Clin Ophthalmol       Date:  2007-09

7.  Genetic screening for OPA1 and OPA3 mutations in patients with suspected inherited optic neuropathies.

Authors:  Patrick Yu-Wai-Man; Suma P Shankar; Valérie Biousse; Neil R Miller; Lora J H Bean; Bradford Coffee; Madhuri Hegde; Nancy J Newman
Journal:  Ophthalmology       Date:  2010-10-30       Impact factor: 12.079

8.  Clinical and molecular genetic findings in autosomal dominant OPA3-related optic neuropathy.

Authors:  Panagiotis I Sergouniotis; Rahat Perveen; Dawn L Thiselton; Konstantinos Giannopoulos; Marios Sarros; Jennifer R Davies; Susmito Biswas; Alec M Ansons; Jane L Ashworth; I Christopher Lloyd; Graeme C Black; Marcela Votruba
Journal:  Neurogenetics       Date:  2014-08-27       Impact factor: 2.660

9.  The prevalence and natural history of dominant optic atrophy due to OPA1 mutations.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Ailbhe Burke; Peter W Sellar; Michael P Clarke; Lawrence Gnanaraj; Desiree Ah-Kine; Gavin Hudson; Birgit Czermin; Robert W Taylor; Rita Horvath; Patrick F Chinnery
Journal:  Ophthalmology       Date:  2010-04-24       Impact factor: 12.079

10.  Mutation survey of the optic atrophy 1 gene in 193 Chinese families with suspected hereditary optic neuropathy.

Authors:  Yabin Chen; Xiaoyun Jia; Panfeng Wang; Xueshan Xiao; Shiqiang Li; Xiangming Guo; Qingjiong Zhang
Journal:  Mol Vis       Date:  2013-02-06       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.